8 rempart de la vierge
Namur, 5000
Belgium
University of Namur
SARS-CoV-2, vaccine booster, humoral response, BNT162b2, mRNA-1273, Omicron.
Covid-19, sialic acid, variants of concern, antivirals, glycoclusters, multivalency
COVID-19, sialic acid, variants of concern, antivirals, glycoclusters, multivalency
Advanced therapy, ATMP, Hemocompatibility, Regulatory frameworks, Thrombo-inflammation
Keywords: Maternal immunity, neutralizing antibodies, passive immunity, SARS-CoV-2, pregnancy
glioblastoma, GFAP, liquid biopsy, biomarkers
Neutrophils, viability, purity, activation, reference interval, flow cytometry